Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Fujimura

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|June 2, 2020
Identification of a novel nucleolar protein complex required for mitotic chromosome segregation through centromeric accumulation of Aurora BAkiko Fujimura, Yuki Hayashi, Kazashi Kato, et al.
Nature Communications|January 11, 2023
TLR3 forms a laterally aligned multimeric complex along double-stranded RNA for efficient signal transductionKentaro Sakaniwa, Akiko Fujimura, Takuma Shibata, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Live-cell epigenome manipulation by synthetic histone acetylation catalyst systemYusuke Fujiwara, Yuki Yamanashi, Akiko Fujimura, et al.
Oncology Reports|March 2, 2021
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancerShu Ichimiya, Hideya Onishi, Shinjiro Nagao, et al.
Cellular Immunology|November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytesKazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2019
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitorAkiko Fujimura, Kazunori Nakayama, Akira Imaizumi, et al.
Anticancer Research|May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic CancerHideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.
FEBS Open Bio|June 11, 2021
Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinomaYuki Sekino, Akira Imaizumi, Noritaka Komune, et al.
Biochemical and Biophysical Research Communications|March 22, 2008
PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1Yoko Komatsu, Ichiaki Ito, Mitsutoshi Wayama, et al.
Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|June 2, 2020
Identification of a novel nucleolar protein complex required for mitotic chromosome segregation through centromeric accumulation of Aurora BAkiko Fujimura, Yuki Hayashi, Kazashi Kato, et al.
Nature Communications|January 11, 2023
TLR3 forms a laterally aligned multimeric complex along double-stranded RNA for efficient signal transductionKentaro Sakaniwa, Akiko Fujimura, Takuma Shibata, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
Live-cell epigenome manipulation by synthetic histone acetylation catalyst systemYusuke Fujiwara, Yuki Yamanashi, Akiko Fujimura, et al.
Oncology Reports|March 2, 2021
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancerShu Ichimiya, Hideya Onishi, Shinjiro Nagao, et al.
Cellular Immunology|November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytesKazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2019
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitorAkiko Fujimura, Kazunori Nakayama, Akira Imaizumi, et al.
Anticancer Research|May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic CancerHideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.
FEBS Open Bio|June 11, 2021
Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinomaYuki Sekino, Akira Imaizumi, Noritaka Komune, et al.
Biochemical and Biophysical Research Communications|March 22, 2008
PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1Yoko Komatsu, Ichiaki Ito, Mitsutoshi Wayama, et al.
Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.
Pageof 4